Categories: News

Vivalink Announces World’s First Multi-Vital Blood Pressure Patch for Remote Patient Monitoring

Integrated patch offers ECG, heart rate, respiratory rate, and blood pressure monitoring for commercial research and development                       

CAMPBELL, Calif., May 3, 2022 /PRNewswire/ — Vivalink, a leading provider of digital healthcare solutions, announces availability of the world’s first multi-vital blood pressure patch for remote patient monitoring for use in commercial research and development. The advanced multimodal continuous signal processing patch uses electrical signal-based technologies to capture ECG trace, heart rate, respiratory rate, systolic and diastolic blood pressure on a single device. The device is FDA/NMPA cleared for ECG and heart rate, and CE cleared for ECG, heart rate and respiratory rate. The blood pressure feature is integrated and available for research and development. Weighing just 7.5 grams and the size of a small bandage, the reusable and rechargeable wearable patch requires no additional components such as a wristband or wires in order to capture blood pressure.

Designed for remote and ambulatory patient monitoring such as hypertension diagnosis and management, the patch is wireless network enabled to automatically capture and send a continuous stream of data to clinical applications in the cloud. In addition, the patch contains on-board memory in order to capture data during network outages, and then automatically synchronize the data once network connections are re-established.

Key benefits of the blood pressure feature include automated readings of systolic and diastolic pressure. The water resistant patch can be worn inconspicuously throughout the day to capture blood pressure and other key vitals in remote settings and during sleep. Validation of the blood pressure capability was conducted in accordance with ISO 81060-2 standards over a range of physiological profiles.

Development of the advanced blood pressure algorithm is enabled by the use of Vivalink’s Biometrics Data Platform which is uniquely designed to provide uninterrupted streams of real-world physiological data for AI development. Other advanced algorithms in development using the Biometrics Data Platform include cardiac mechanics and hemodynamics.

“We pride ourselves in continuous innovation,” said Jiang Li, CEO at Vivalink. “This milestone further establishes Vivalink as a leader and innovator in the remote patient monitoring market.”

The multi-vital blood pressure patch is available now for commercial research and development. For more information or to inquire about early access contact Vivalink at: https://www.vivalink.com/.

About Vivalink
Vivalink is a provider of digital healthcare solutions for virtual patient care and decentralized clinical trials. We leverage unique physiology-optimized medical wearable sensors and data services to enable a deeper and more clinical understanding between provider and patient.

Media Contact:
pr@vivalink.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vivalink-announces-worlds-first-multi-vital-blood-pressure-patch-for-remote-patient-monitoring-301538299.html

SOURCE Vivalink

Staff

Recent Posts

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN…

11 hours ago

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB)…

11 hours ago

Lowell Farms Inc. Announces Change of Chief Financial Officer

SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL;…

11 hours ago

PetVivo Reports Reports Fiscal 2024 Results

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW),…

11 hours ago

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…

11 hours ago

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a…

11 hours ago